Quinidine Sulfate Market Size to Grow by USD 427.29 mn, North America to be Largest Contributor to Market Growth - Technavio

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- The quinidine sulfate market has been segmented by disease type (malaria and arrhythmias) and geography (North America, Europe, Asia, and Rest of World (ROW)). North America will account for 37% of the market's growth during the forecast period. This growth is attributed to factors such as the increased funding for the development of anti-malarial medicines. However, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the quinidine sulfate market in North America.

The quinidine sulfate market size is expected to grow by USD 427.29 mn from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 6.7% during the forecast period.

Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format

Company Profiles

The quinidine sulfate market is concentrated, and the vendors are deploying organic and inorganic growth strategies to compete in the market. Vendors in the global quinidine sulfate market are continuously undergoing mergers and acquisitions to broaden their product portfolios and strengthen their positions.

Some of the companies covered in this report are Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. The key offerings of a few of these vendors are listed below:

• Bennet Pharmaceuticals Ltd. - The company offers quindine sulfate, namely Quinet.
• Cipla Ltd. - The company offers quinidine sulfate products in pharmaceutical ingredients.
• Ipca Laboratories Ltd. - The company offers quinidine sulfate products such as qinarsol tablets and injections.
• Merck and Co. Inc. - The company offers quindine sulfate, namely Cinkona.
• PRISM INDUSTRIES LTD. - The company offers quinidine sulfate products such as queenolar 150, 300, and 600.

Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now

Market Dynamics

The growing incidence of malaria is driving the quinidine sulfate market growth. However, factors such as the emergence of insecticide-resistant vectors may challenge the market growth.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

Competitive Analysis

The report includes competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Want your report customized? Speak to an analyst and personalize your report according to your needs

Related Reports

Pregabalin Market by Application and Geography - Forecast and Analysis 2022-2026: The pregabalin market share is expected to increase by USD 153.03 million from 2021 to 2026.

Cell and Gene Therapy Market by Type and Geography - Forecast and Analysis 2022-2026: The cell and gene therapy market share is expected to increase by USD 9.97 billion from 2021 to 2026.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

• 5.1 Market segments 
• Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)

• 5.2 Comparison by Disease Type 
• Exhibit 26: Chart on Comparison by Disease Type
• Exhibit 27: Data Table on Comparison by Disease Type

• 5.3 Malaria - Market size and forecast 2021-2026
• Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)

• 5.4 Arrhythmias - Market size and forecast 2021-2026
• Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Disease Type 
• Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Bennet Pharmaceuticals Ltd. 
• Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
• Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
• Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings

• 10.4 Buchler GmbH 
• Exhibit 88: Buchler GmbH - Overview
• Exhibit 89: Buchler GmbH - Product / Service
• Exhibit 90: Buchler GmbH - Key offerings

• 10.5 Cipla Ltd. 
• Exhibit 91: Cipla Ltd. - Overview
• Exhibit 92: Cipla Ltd. - Business segments
• Exhibit 93: Cipla Ltd. - Key news
• Exhibit 94: Cipla Ltd. - Key offerings
• Exhibit 95: Cipla Ltd. - Segment focus

• 10.6 Ipca Laboratories Ltd. 
• Exhibit 96: Ipca Laboratories Ltd. - Overview
• Exhibit 97: Ipca Laboratories Ltd. - Product / Service
• Exhibit 98: Ipca Laboratories Ltd. - Key offerings

• 10.7 Lark Laboratories India Ltd. 
• Exhibit 99: Lark Laboratories India Ltd. - Overview
• Exhibit 100: Lark Laboratories India Ltd. - Product / Service
• Exhibit 101: Lark Laboratories India Ltd. - Key offerings

• 10.8 Merck and Co. Inc. 
• Exhibit 102: Merck and Co. Inc. - Overview
• Exhibit 103: Merck and Co. Inc. - Business segments
• Exhibit 104: Merck and Co. Inc. - Key news
• Exhibit 105: Merck and Co. Inc. - Key offerings
• Exhibit 106: Merck and Co. Inc. - Segment focus

• 10.9 Merck KGaA 
• Exhibit 107: Merck KGaA - Overview
• Exhibit 108: Merck KGaA - Business segments
• Exhibit 109: Merck KGaA - Key news
• Exhibit 110: Merck KGaA - Key offerings
• Exhibit 111: Merck KGaA - Segment focus

• 10.10 PRISM INDUSTRIES LTD. 
• Exhibit 112: PRISM INDUSTRIES LTD. - Overview
• Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
• Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings

• 10.11 Teva Pharmaceutical Industries Ltd. 
• Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus

• 10.12 VIVAN Life Sciences Pvt. Ltd. 
• Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
• Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
• Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 123: Inclusions checklist
• Exhibit 124: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 125: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 126: Research methodology
• Exhibit 127: Validation techniques employed for market sizing
• Exhibit 128: Information sources

• 11.5 List of abbreviations 
• Exhibit 129: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio